|
Updated Results from the Phase II Study of Hyper-CVAD in Combination with Ofatumumab as Frontline Therapy for Adults with CD20 Positive (CD20+) ALL |
|
|
|
Title: |
Updated Results from the Phase II Study of Hyper-CVAD in Combination with Ofatumumab as Frontline Therapy for Adults with CD20 Positive (CD20+) ALL |
Author: |
Issa, Ghayas Kantarjian, Hagop Ravandi, Farhad Thomas, Deborah Khouri, Maria Manero, Guillermo Garcia Garris, Rebecca Cortes, Jorge Short, Nicholas Sasaki, Koji Schroeder, Heather Kadia, Tapan Verstovsek, Srdan Daver, Naval Jain, Nitin Konopleva, Marina O'Brien, Susan Jabbour, Elias |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 16 (2016) nr. S2 pages 1 p. |
Year: |
2016 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|